Investors Title (NASDAQ:ITIC) Stock Rating Lowered by Wall Street Zen

Investors Title (NASDAQ:ITIC) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Wednesday.

Separately, Weiss Ratings raised Investors Title from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, July 1st. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has an average rating of “Buy”.

Investors Title Stock Up 2.2%

ITIC stock opened at $295.43 on Wednesday. The business’s fifty day moving average is $269.61 and its 200-day moving average is $249.12. The company has a market cap of $557.77 million, a P/E ratio of 14.70 and a beta of 0.63. Investors Title has a twelve month low of $209.75 and a twelve month high of $297.31.

Investors Title (NASDAQ:ITIC) last posted its quarterly earnings results on Thursday, August 6th. The insurance provider reported $7.73 earnings per share (EPS) for the quarter. Investors Title had a return on equity of 14.03% and a net margin of 13.59%.The business had revenue of $81.71 million for the quarter.

Insiders Place Their Bets

In other news, Director Jr. Elton C. Parker purchased 538 shares of Investors Title stock in a transaction dated Wednesday, May 13th. The shares were bought at an average cost of $231.00 per share, with a total value of $124,278.00. Following the completion of the transaction, the director directly owned 3,750 shares in the company, valued at $866,250. This trade represents a 16.75% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 25.96% of the company’s stock.

Institutional Trading of Investors Title

Large investors have recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co boosted its holdings in shares of Investors Title by 34.0% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 193 shares of the insurance provider’s stock valued at $48,000 after buying an additional 49 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Investors Title by 6.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 803 shares of the insurance provider’s stock worth $201,000 after acquiring an additional 49 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Investors Title by 4.0% during the second quarter. Invesco Ltd. now owns 1,622 shares of the insurance provider’s stock worth $343,000 after acquiring an additional 63 shares during the period. Royal Bank of Canada raised its holdings in shares of Investors Title by 2.3% during the first quarter. Royal Bank of Canada now owns 3,937 shares of the insurance provider’s stock worth $949,000 after acquiring an additional 88 shares during the period. Finally, First Trust Advisors LP raised its holdings in shares of Investors Title by 1.9% during the third quarter. First Trust Advisors LP now owns 4,839 shares of the insurance provider’s stock worth $1,296,000 after acquiring an additional 90 shares during the period. Institutional investors own 41.40% of the company’s stock.

About Investors Title

Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies. It offers services in connection with tax-deferred exchanges of like-kind property; acts as a qualified intermediary in tax-deferred exchanges of property; coordinates the exchange aspects of the real estate transaction, such as drafting standard exchange documents, holding the exchange funds between the sale of the old property and the purchase of the new property, and accepting the formal identification of the replacement property.